

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding and managing hairy... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-509/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-509" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding and managing hairy cell leukemia" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding and managing hairy cell leukemia.">
            <meta name="og:description" content="Read the latest article version by Tobias Roider, Brunangelo Falini, Sascha Dietrich, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="14391">
            <meta name="article-id" content="13265">
            <meta name="dc.title" content="Recent advances in understanding and managing hairy cell leukemia">
            <meta name="dc.description" content="Hairy cell leukemia is a rare B-cell malignancy that is characterized by an indolent course. It was initially described as a distinct entity in 1958. Before the establishment of modern treatment, median survival was only 4 years. Since then, major advances in the treatment and understanding of the biology and genomic landscape of hairy cell leukemia have been made. This review summarizes the present understanding of hairy cell leukemia with particular focus on the development of novel and targeted approaches to treatment.">
            <meta name="dc.subject" content="hairy cell leukemia, BRAF, vemurafenib">
            <meta name="dc.creator" content="Roider, Tobias">
            <meta name="dc.creator" content="Falini, Brunangelo">
            <meta name="dc.creator" content="Dietrich, Sascha">
            <meta name="dc.date" content="2018/04/27">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.13265.1">
            <meta name="dc.source" content="F1000Research 2018 7:509">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="hairy cell leukemia">
            <meta name="prism.keyword" content="BRAF">
            <meta name="prism.keyword" content="vemurafenib">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/04/27">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="509">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.13265.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-509">
            <meta name="citation_title" content="Recent advances in understanding and managing hairy cell leukemia">
            <meta name="citation_abstract" content="Hairy cell leukemia is a rare B-cell malignancy that is characterized by an indolent course. It was initially described as a distinct entity in 1958. Before the establishment of modern treatment, median survival was only 4 years. Since then, major advances in the treatment and understanding of the biology and genomic landscape of hairy cell leukemia have been made. This review summarizes the present understanding of hairy cell leukemia with particular focus on the development of novel and targeted approaches to treatment.">
            <meta name="citation_description" content="Hairy cell leukemia is a rare B-cell malignancy that is characterized by an indolent course. It was initially described as a distinct entity in 1958. Before the establishment of modern treatment, median survival was only 4 years. Since then, major advances in the treatment and understanding of the biology and genomic landscape of hairy cell leukemia have been made. This review summarizes the present understanding of hairy cell leukemia with particular focus on the development of novel and targeted approaches to treatment.">
            <meta name="citation_keywords" content="hairy cell leukemia, BRAF, vemurafenib">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Tobias Roider">
            <meta name="citation_author_institution" content="Department of Medicine V, University of Heidelberg, Heidelberg, Germany">
            <meta name="citation_author" content="Brunangelo Falini">
            <meta name="citation_author_institution" content="Institute of Hematology and Center for Hemato-Oncology Research (CREO), University and Hospital of Perugia, Perugia, Italy">
            <meta name="citation_author" content="Sascha Dietrich">
            <meta name="citation_author_institution" content="Department of Medicine V, University of Heidelberg, Heidelberg, Germany">
            <meta name="citation_publication_date" content="2018/04/27">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="509">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.13265.1">
            <meta name="citation_firstpage" content="509">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-509/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-509.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=14391 /> <input type=hidden id=articleId name=articleId value=13265 /> <input type=hidden id=xmlUrl value="/articles/7-509/v1/xml"/> <input type=hidden id=xmlFileName value="-7-509-v1.xml"> <input type=hidden id=article_uuid value=7a150471-ec1c-4a00-8e4f-87e1ce1dfe52 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding and managing hairy cell leukemia"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.13265.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.13265.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-509"
  },
  "headline": "Recent advances in understanding and managing hairy cell leukemia",
  "datePublished": "2018-04-27T11:59:56",
  "dateModified": "2018-04-27T11:59:56",
  "author": [
    {
      "@type": "Person",
      "name": "Tobias Roider"
    },    {
      "@type": "Person",
      "name": "Brunangelo Falini"
    },    {
      "@type": "Person",
      "name": "Sascha Dietrich"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Hairy cell leukemia is a rare B-cell malignancy that is characterized by an indolent course. It was initially described as a distinct entity in 1958. Before the establishment of modern treatment, median survival was only 4 years. Since then, major advances in the treatment and understanding of the biology and genomic landscape of hairy cell leukemia have been made. This review summarizes the present understanding of hairy cell leukemia with particular focus on the development of novel and targeted approaches to treatment."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-509/v1",
            "name": "Recent advances in understanding and managing hairy cell leukemia"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding and managing hairy cell leukemia </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=14391 data-id=13265 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13265.1" data-recommended="" data-doi="10.12688/f1000research.13265.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-509/v1/pdf?article_uuid=7a150471-ec1c-4a00-8e4f-87e1ce1dfe52" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-13265-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-13265-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-13265-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Roider T, Falini B and Dietrich S. Recent advances in understanding and managing hairy cell leukemia [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):509 (<a class=new-orange href="https://doi.org/10.12688/f1000research.13265.1" target=_blank>https://doi.org/10.12688/f1000research.13265.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-13265-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=13265 id=track-article-signin-13265 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13265?target=/articles/7-509/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=14391 /> <input name=articleId type=hidden value=13265 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding and managing hairy cell leukemia</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Tobias Roider<a href="https://orcid.org/0000-0002-6973-3531" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6973-3531</div><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:brunangelo.falini@unipg.it" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Brunangelo Falini</span></a><sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:sascha.dietrich@med.uni-heidelberg.de" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sascha Dietrich</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Tobias Roider<a href="http://orcid.org/0000-0002-6973-3531" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6973-3531</div><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:brunangelo.falini@unipg.it" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Brunangelo Falini</span></a><sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:sascha.dietrich@med.uni-heidelberg.de" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sascha Dietrich</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 27 Apr 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.13265.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medicine V, University of Heidelberg, Heidelberg, Germany<br/> <sup>2</sup> Institute of Hematology and Center for Hemato-Oncology Research (CREO), University and Hospital of Perugia, Perugia, Italy<br/> <p> <div class=margin-bottom> Tobias Roider <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Brunangelo Falini <br/> <span>Roles: </span> Conceptualization, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Sascha Dietrich <br/> <span>Roles: </span> Conceptualization, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=33747-33304></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=33748-33307></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=33750-33306></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=33749-33305></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Hairy cell leukemia is a rare B-cell malignancy that is characterized by an indolent course. It was initially described as a distinct entity in 1958. Before the establishment of modern treatment, median survival was only 4 years. Since then, major advances in the treatment and understanding of the biology and genomic landscape of hairy cell leukemia have been made. This review summarizes the present understanding of hairy cell leukemia with particular focus on the development of novel and targeted approaches to treatment. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> hairy cell leukemia, BRAF, vemurafenib </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Brunangelo Falini (<a href="mailto:brunangelo.falini@unipg.it">brunangelo.falini@unipg.it</a>) <br> Sascha Dietrich (<a href="mailto:sascha.dietrich@med.uni-heidelberg.de">sascha.dietrich@med.uni-heidelberg.de</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Brunangelo Falini, Sascha Dietrich </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> Sascha Dietrich was supported by a grant of the Hairy Cell Leukemia Foundation, the Heidelberg Research Centre for Molecular Medicine (HRCMM), and a BMBF Junior Group grant. <br/> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2018 Roider T <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Roider T, Falini B and Dietrich S. Recent advances in understanding and managing hairy cell leukemia [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):509 (<a href="https://doi.org/10.12688/f1000research.13265.1" target=_blank>https://doi.org/10.12688/f1000research.13265.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 27 Apr 2018, <b>7</b>(F1000 Faculty Rev):509 (<a href="https://doi.org/10.12688/f1000research.13265.1" target=_blank>https://doi.org/10.12688/f1000research.13265.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 27 Apr 2018, <b>7</b>(F1000 Faculty Rev):509 (<a href="https://doi.org/10.12688/f1000research.13265.1" target=_blank>https://doi.org/10.12688/f1000research.13265.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d21832e186>Introduction</h2><p class="" id=d21832e189>Hairy cell leukemia (HCL) is a rare mature B-cell malignancy, which was initially described by Bouroncle <i>et al</i>. in 1958<sup><a href="#ref-1">1</a></sup>. HCL has an incidence of 0.3 cases per 100,000 individuals<sup><a href="#ref-2">2</a></sup>. It occurs about four times more often in men than in women, with a median age at diagnosis of 55 years<sup><a href="#ref-3">3</a></sup>. HCL cells are characterized by thin cytoplasmic hair-like projections, giving the disease its name<sup><a href="#ref-4">4</a></sup>. Leukemic hairy cells accumulate in the bone marrow and cause pancytopenia, which is the most common finding at initial presentation. HCL patients report symptoms of fatigue, infections, and, occasionally, left-sided abdominal pain caused by splenomegaly. In contrast to many B-cell malignancies, lymphadenopathy is rare in HCL patients<sup><a href="#ref-5">5</a></sup>. A severe fibrotic reaction is commonly found in the bone marrow of HCL patients, which often complicates a diagnostic bone marrow aspiration. The diagnosis is usually based on the detection of typical morphological features and a unique immunophenotype with flow cytometry of peripheral blood and/or histological and immunohistochemical (IHC) analysis of trephine biopsies. HCL cells show a characteristic gene expression profile signature that points to their origin from memory B cells<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Although standard treatment with purine analogues is very effective in the majority of patients with HCL, there is a small subset of relapsed and refractory HCL patients who qualify for investigational therapies with monoclonal antibodies or small molecule compounds<sup><a href="#ref-8">8</a></sup>. In this review, we will discuss these novel therapeutic agents as well as recent advances in understanding the molecular pathogenesis of HCL.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21832e230>The biology of HCL</h2><p class="" id=d21832e233>In 2011, Tiacci <i>et al</i>. discovered that classical HCL is characterized by a gain-of-function mutation of the BRAF serine/threonine protein kinase (V600E)<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a></sup>. In the initial validation series, all HCL patients showed this particular mutation, while a set of 195 B-cell lymphomas and leukemias did not harbor a mutated <i>BRAF</i> gene. The vast majority of <i>BRAF</i>-V600E mutations in HCL are heterozygous. Homozygous mutations are rare but have been suggested to be associated with a more aggressive disease course<sup><a href="#ref-11">11</a></sup>. Recurrent deletions of the <i>BRAF</i> gene locus on chromosome 7q34 have been described in HCL and lead to loss of heterozygosity<sup><a href="#ref-12">12</a></sup>. <i>BRAF</i> mutations, different from V600E, seem to be extremely rare in HCL and have been described in only two patients so far<sup><a href="#ref-13">13</a></sup>. The incidence of <i>BRAF</i> mutations in nearly 100% of HCL cases at diagnosis (encompassing the whole disease spectrum), their somatic nature, their presence in the entire tumor clone, and their high stability at relapse strongly suggest that the pathogenesis of HCL critically depends on constitutively activated BRAF<sup><a href="#ref-10">10</a>,<a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>.</p><p class="" id=d21832e284>Chung <i>et al</i>. reported that <i>BRAF</i>-V600E mutations are already present in hematopoietic stem cells (HSCs) or B-cell lymphoid progenitors of HCL patients and that these patients exhibit marked alterations in hematopoietic stem/progenitor cell (HSPC) frequencies<sup><a href="#ref-16">16</a></sup>. Transplantation of <i>BRAF</i>-V600E-mutant HSCs from an HCL patient into immunodeficient mice resulted in stable engraftment of <i>BRAF</i>-V600E-mutant human hematopoietic cells, revealing the functional self-renewal capacity of HCL HSCs. However, none of the transplanted mice developed typical HCL, strongly suggesting that the development of a full HCL phenotype may require a permissive epigenetic background (likely restricted to a particular stage of B-cell differentiation) and/or the acquirement of further genetic lesions<sup><a href="#ref-16">16</a></sup>.</p><p class="" id=d21832e308>The <i>BRAF</i>-V600E mutation constitutively activates BRAF, providing oncogenic signaling through the MEK-ERK cascade<sup><a href="#ref-10">10</a>,<a href="#ref-17">17</a></sup> (<a href="#f1">Figure 1</a>). Both <i>in vitro</i> and <i>in vivo</i> studies have demonstrated that BRAF-dependent phospho-ERK activation is a critical signaling event in HCL<sup><a href="#ref-10">10</a>,<a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. Moreover, <i>in vitro</i> treatment of primary purified HCL cells with BRAF and MEK inhibitors has resulted in marked dephosphorylation of MEK/ERK, silencing of the RAF-MEK-ERK pathway transcriptional output, loss of the specific HCL gene expression profile signature, change of the characteristic morphology of the leukemic cells (from hairy to smooth), and eventually apoptosis<sup><a href="#ref-14">14</a>,<a href="#ref-15">15</a>,<a href="#ref-20">20</a></sup>.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/14391/d37d4574-43e3-472f-9b1b-ed10c6ebed5f_figure1.gif"><img alt="d37d4574-43e3-472f-9b1b-ed10c6ebed5f_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/14391/d37d4574-43e3-472f-9b1b-ed10c6ebed5f_figure1.gif"></a><div class=caption><h3>Figure 1. RAF-MEK-ERK signaling pathway in hairy cell leukemia.</h3><p id=d21832e364>The figure shows the RAF-MEK-ERK signaling pathway in hairy cell leukemia and highlights targets for therapeutic intervention.</p></div></div><p class="" id=d21832e372>Aberrant expression of cell cycle-related proteins such as cyclin D1 has been shown to be reversible using inhibitors of activated BRAF signaling, suggesting that expression is not a constitutive disease trait but elicited by MEK/ERK signaling and oncogenic BRAF mutations, respectively<sup><a href="#ref-18">18</a></sup>. This could have a significant effect on the assessment of minimal residual disease (MRD) when considering inhibitor treatment because the profile of the marker cyclin D1 might be dynamic, as well as on targeted drug therapy, which may be shortened due to the on-target effect of inhibitors.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21832e382>Differential diagnosis of HCL</h2><p class="" id=d21832e385>Historically, there were two different forms of HCL: the more-common classical HCL (90%) and the less-frequent HCL variant (10%). HCL variant is characterized by a more aggressive disease course and poor response to purine analogs<sup><a href="#ref-21">21</a></sup>. Most importantly, HCL variant cases are commonly negative for <i>BRAF</i>-V600E mutation, indicating that HCL variant is a biologically distinctive entity. A small subset of patients with bona fide classical (HCL) who also do not harbor any <i>BRAF</i> mutation has been reported only in a single study<sup><a href="#ref-22">22</a></sup>. However, these cases are often characterized by an IGHV4-34 immunoglobulin rearrangement, which is in general absent in classical HCL and is associated with as poor a prognosis as HCL variant<sup><a href="#ref-22">22</a></sup>.</p><p class="" id=d21832e406>Almost 50% of HCL-variant and IGHV4-34-expressing HCL cases were found to harbor activating mutations in the <i>MAP2K1</i> gene encoding MEK1<sup><a href="#ref-23">23</a></sup>. All but one of the identified mutations (n=15) have been described and are known to strongly increase phospho-ERK levels and consequently cell proliferation<sup><a href="#ref-23">23</a></sup>. These findings underline the importance of constitutive MEK-ERK signaling, even in this HCL-like disorder.</p><p class="" id=d21832e420>HCL cells typically show a distinctive immunophenotype co-expressing CD19, CD20, CD11c, CD25, CD103, and CD123. In contrast, HCL variant lacks the expression of CD25 and CD123<sup><a href="#ref-24">24</a></sup>. Moreover, HCL cells strongly express CD200, which can also be used as another distinctive marker to differentiate HCL<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>. <i>BRAF</i>-V600E is now regarded as a specific oncogenic mutation occurring only in HCL<sup><a href="#ref-27">27</a></sup>. Another distinctive feature of HCL is the expression of annexin A1, which is easily accessible by immunohistochemical staining<sup><a href="#ref-28">28</a></sup>. In addition to HCL variant, the 2016 revision of WHO classification of lymphoid neoplasms recognizes two other entities resembling HCL: splenic marginal zone lymphoma (SMZL), usually associated with <i>NOTCH2</i> mutations, and splenic diffuse red pulp small B-cell lymphoma (SDRPBCL), still listed as a provisional entity, whose genomic landscape has not been yet clarified<sup><a href="#ref-27">27</a></sup>. <a href="#T1">Table 1</a> summarizes the most important differential diagnoses of HCL and their characteristic markers.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Differential diagnoses in HCL and their characteristic features.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21832e467 class=n-a></a><thead><a name=d21832e469 class=n-a></a><tr><a name=d21832e471 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d21832e473 class=n-a></a></th><th align=left colspan=1 rowspan=1><a name=d21832e475 class=n-a></a>HCL</th><th align=left colspan=1 rowspan=1><a name=d21832e478 class=n-a></a>HCL variant</th><th align=left colspan=1 rowspan=1><a name=d21832e481 class=n-a></a>SMZL</th><th align=left colspan=1 rowspan=1><a name=d21832e484 class=n-a></a>SDRPBCL</th></tr></thead><tbody><a name=d21832e489 class=n-a></a><tr><a name=d21832e491 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e493 class=n-a></a><b>Frequency</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e497 class=n-a></a>0.3/100,000</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e500 class=n-a></a>0.03/100,000</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e503 class=n-a></a>0.13/100,000</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e506 class=n-a></a>n/a</td></tr><tr><a name=d21832e510 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e512 class=n-a></a><b>Ratio m:f</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e516 class=n-a></a>4:1 (m:w)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e519 class=n-a></a>12:1 (m:w)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e522 class=n-a></a>1:3 (m:w)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e525 class=n-a></a>12:1 (m:w)</td></tr><tr><a name=d21832e529 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e531 class=n-a></a><b>Median age</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e535 class=n-a></a>5055</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e538 class=n-a></a>&gt;70</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e541 class=n-a></a>6570</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e544 class=n-a></a>6575</td></tr><tr><a name=d21832e548 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e550 class=n-a></a><b>Lymphocytosis</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e554 class=n-a></a>10%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e557 class=n-a></a>90%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e560 class=n-a></a>50%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e563 class=n-a></a>50%</td></tr><tr><a name=d21832e567 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e569 class=n-a></a><b>Immunophenotype</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e573 class=n-a></a>CD11c<sup>+</sup><br class=br>CD103<sup>+</sup><br class=br>CD25<sup>+</sup><br class=br>CD200<sup>+</sup><br class=br>CD23<sup>-</sup><br class=br>CD5<sup>-</sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e599 class=n-a></a>CD11c<sup>+</sup><br class=br>CD103<sup>+/<sup>-</sup></sup><br class=br>CD25<sup>-</sup><br class=br>CD200<sup>-</sup><br class=br>CD23<sup>-</sup><br class=br>CD5<sup>-</sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e627 class=n-a></a>CD11c<sup>-</sup><br class=br>CD103<sup>+/<sup>-</sup></sup><br class=br>CD5<sup>+/<sup>-</sup></sup><br class=br>CD200<sup>+</sup><br class=br>CD23<sup>+/<sup>-</sup></sup><br class=br>CD5<sup>+/<sup>-</sup></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e661 class=n-a></a>CD11c<sup>+</sup><br class=br>CD103<sup>-</sup><br class=br>CD25<sup>+/<sup>-</sup></sup><br class=br><br class=br>CD23<sup>-</sup><br class=br>CD5<sup>+/<sup>-</sup></sup></td></tr><tr><a name=d21832e690 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e692 class=n-a></a><b>Immunohistochemistry</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e696 class=n-a></a>DBA.44<sup>+</sup><br class=br>Cyclin D1<sup>+</sup><br class=br>Annexin A1<sup>+</sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e709 class=n-a></a>DBA.44<sup>+</sup><br class=br>Cyclin D1<sup>+/<sup>-</sup></sup><br class=br>Annexin A1<sup>-</sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e724 class=n-a></a>DBA.44<sup>+</sup><br class=br>Cyclin D1<sup>-</sup><br class=br>Annexin A1<sup>-</sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e737 class=n-a></a>DBA.44<sup>+</sup><br class=br>Cyclin D1<sup>-</sup><br class=br>Annexin A1<sup>-</sup></td></tr><tr><a name=d21832e751 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e753 class=n-a></a><b>Genotype</b></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e757 class=n-a></a><i>BRAF</i>-V600E<br class=br>mutation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e764 class=n-a></a><i>BRAF</i> wildtype, 50% <i>MEK1</i><br class=br>mutations, 50% IGHV4-34<br class=br>rearrangement</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e775 class=n-a></a><i>BRAF</i> wildtype,<br class=br>frequent <i>NOTCH2</i> mutations</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21832e785 class=n-a></a><i>BRAF</i> wildtype</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d21832e795 class=n-a></a><p id=d21832e797> HCL, hairy cell leukemia; IGHV, immunoglobulin heavy-chain variable; SDRPBCL, splenic diffuse red pulp small B-cell lymphoma; SMZL, splenic marginal zone lymphoma</p></div></div></div><p class="" id=d21832e804>Testing for the <i>BRAF</i>-V600E mutation in routine clinical practice can be helpful as an additional marker if there is any diagnostic uncertainty. For relapsed and refractory patients, we strongly recommend evaluating the <i>BRAF</i> mutation status, since this may serve as a therapeutic target. The limited number of HCL cells present in the peripheral blood requires highly sensitive molecular assays to detect <i>BRAF</i> mutations (e.g. allele-specific polymerase chain reaction)<sup><a href="#ref-9">9</a></sup>. Alternatively, <i>BRAF</i>-V600E mutation-specific antibodies can be used for immunohistochemical staining in bone marrow biopsies<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. However, further validation of the diagnostic utility of these reagents in a larger number of cases is required.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21832e834>Cooperating mutations of <i>BRAF</i>-V600E in HCL</h2><p class="" id=d21832e840>In addition to the <i>BRAF</i>-V600E mutation, the most common genetic alteration in classical HCL was a copy number loss of chromosome 7q. The minimally deleted region of this copy number alteration includes the wild-type locus of <i>BRAF</i>. This genetic lesion subdivides individuals with classical HCL into those with hemizygous versus heterozygous mutations of <i>BRAF</i><sup><a href="#ref-12">12</a></sup>. A whole-exome sequencing study of relapsed and refractory HCL patients revealed known cancer-associated genes, such as <i>EZH2</i> and <i>ARID1A,</i> as well as novel inactivating mutations of the cell cycle inhibitor <i>CDKN1B</i> (p27)<sup><a href="#ref-31">31</a></sup>. In a cohort of 81 mostly untreated HCL patients, the incidence of <i>CDKN1B</i> mutations was 16%<sup><a href="#ref-31">31</a></sup>. While a clinical impact of <i>CDKN1B</i> mutations was not found, the data identify <i>CDKN1B</i> as the second most commonly mutated gene in HCL. <i>CDKN1B</i> is a critical element of cell-cycle control and a known tumor suppressor in different solid cancers<sup><a href="#ref-32">32</a></sup>. <i>CDKN1B</i> prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes and thereby regulates cell-cycle progression in the G1 phase. Interestingly, BRAF-induced senescence in premalignant naevi is circumvented by deletion or mutation of <i>CDKN2A</i> in invasive melanoma<sup><a href="#ref-33">33</a></sup>. In <i>BRAF</i>-mutated hairy cell leukemia, <i>CDKN1B</i> loss may serve as a mechanism to escape oncogene-induced senescence<sup><a href="#ref-31">31</a></sup>. In addition to <i>CDKN1B</i> mutations cooperating with <i>BRAF</i>-V600E, recurrent, inactivating mutations in <i>KMT2C</i> (<i>MLL3</i>) were identified in 15% and 13% of classical HCL and HCL variant, respectively<sup><a href="#ref-12">12</a></sup>. Another study described somatic mutations or deletions of the <i>Krppel-like factor 2</i> (<i>KLF2</i>) in 4 of 24 (16%) HCL patients examined<sup><a href="#ref-34">34</a></sup>, but <i>KLF2</i> mutations are more frequent in other B-cell malignancies, such as SMZL (31%) and diffuse large B-cell lymphoma (26%)<sup><a href="#ref-34">34</a>,<a href="#ref-35">35</a></sup>. Although we have better described the genetic landscape of HCL during recent years, the function of mutations cooperating with <i>BRAF</i>-V600E remains to be elucidated.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21832e955>Conventional therapeutic strategies in HCL</h2><p class="" id=d21832e958>At initial diagnosis, most patients will require treatment owing to hematopoietic insufficiency. Accepted indications to start treatment are hemoglobin &lt;11 g/dL, platelet count &lt;100,000/L, or absolute neutrophil count &lt;1,000/L. Less frequently, increased susceptibility to infections or symptomatic splenomegaly may also serve as criteria to start treatment<sup><a href="#ref-5">5</a></sup>. The introduction of the purine analogs cladribine and pentostatin into the treatment landscape of HCL significantly improved the outcome of HCL patients<sup><a href="#ref-36">36</a></sup>. Prospective randomized studies comparing pentostatin and cladribine as first-line treatment have not been conducted, but retrospective studies suggested equivalent activity of both drugs with induction of complete remission (CR) in approximately 85% of untreated patients<sup><a href="#ref-37">37</a><a href="#ref-39">39</a></sup>. The median treatment-free survival for patients with CR after treatment with purine analogs was more than 10 years in most studies<sup><a href="#ref-40">40</a><a href="#ref-42">42</a></sup>. In contrast, patients with a partial remission (PR) had a significantly shorter treatment-free survival of 3 years<sup><a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>. Although achievement of CR, beyond first-line treatment, is associated with similar good outcome, the proportion of patients with insufficient response and early relapse increases with each treatment round<sup><a href="#ref-38">38</a>,<a href="#ref-44">44</a></sup>. Apart from pentostatin and cladribine, there are hardly any effective, approved treatment options: interferon alpha, splenectomy, and rituximab monotherapy should be considered only in a small subset of patients<sup><a href="#ref-5">5</a></sup>. Recently, multiple biology-based treatment options have become available for refractory HCL patients, which will be discussed below.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21832e1006>Therapeutic targeting of <i>BRAF</i>-V600E</h2><p class="" id=d21832e1012>Based on the discovery of the <i>BRAF</i>-V600E mutation in virtually all patients with classical HCL<sup><a href="#ref-10">10</a></sup>, as well as the success of BRAF inhibitor treatment in melanoma<sup><a href="#ref-45">45</a></sup>, it was intuitive that BRAF inhibition is a promising treatment strategy for patients with HCL. The first patient exposed to the BRAF inhibitor vemurafenib indeed showed an immediate and striking response, proving oncogene-dependence and clinical activity<sup><a href="#ref-18">18</a>,<a href="#ref-46">46</a></sup>. The dynamics of the response were notable, with a spleen size reduction of more than 6 cm in only 6 days and improvement of blood count (hemoglobin, platelets, and granulocytes) within 1 month<sup><a href="#ref-46">46</a></sup>. Soon after the initial report, multiple studies confirmed the efficacy of both vemurafenib<sup><a href="#ref-47">47</a><a href="#ref-49">49</a></sup> and (because of availability) later dabrafenib<sup><a href="#ref-50">50</a></sup>. One report also presented the use of vemurafenib in a primary refractory patient with severe pulmonary aspergillosis<sup><a href="#ref-51">51</a></sup>, where the avoidance of myelotoxicity may be particularly advantageous. Individual dosing regimens of vemurafenib with a minimum of 240 mg twice daily were reported in a series of 21 patients with refractory and relapsed HCL. Both antitumor and side effects were found to be independent of vemurafenib dosing<sup><a href="#ref-52">52</a></sup>. Indeed, the initial melanoma study demonstrated response at the 2  240 mg level of dosing. Dose finding studies often pick dose levels based on the incidence of side effects rather than target inhibition. Therefore, the data suggest that individual dosing regimens in BRAF-driven cancers warrant reassessment in trials with implications for cost of cancer care.</p><div class=section><a name=d21832e1057 class=n-a></a><h3 class=section-title>Clinical trials</h3><p class="" id=d21832e1062>Soon after the discovery of <i>BRAF</i>-V600E in HCL, investigators from Italy and the United States designed a single-arm phase II trial testing vemurafenib at standard dosing in relapsed and refractory HCL<sup><a href="#ref-53">53</a></sup>. The Italian study (EudraCT 2011-005487-13) comprised 28 <i>BRAF</i>-V600E-positive HCL patients of whom 21 experienced early relapse after treatment with purine analogs and 15 were disease refractory to prior therapy. Vemurafenib was given for a median of 16 weeks and was reduced to below 2  960 mg in 17 of 28 patients owing to side effects. Drug-related side effects, mostly rash and arthralgia, were generally grade 12 and reversible in all patients. Three patients with either cutaneous basal-cell carcinoma (n=2) or superficial melanoma were all successfully treated with a simple excision. Overall response rate was 96%, with rates of 35% CR and 61% PR obtained after a median of 8 and 9 weeks, respectively. Of note, in all patients with CR, minimal residual disease status was evaluated by immunohistochemistry and showed persisting hairy cells in the range of 10% at the end of treatment. The median relapse-free survival was 9 months; the relapse-free survival was significantly longer among patients who had a CR than among those who had a PR (19 months versus 6 months). In the same report<sup><a href="#ref-53">53</a></sup>, investigators from Memorial Sloan Kettering Cancer Center (MSKCC) reported on 26 patients with HCL who were refractory to purine analogs or who had achieved suboptimal response to purine analogs. Eligible patients received vemurafenib 960 mg twice daily continuously in cycles of 4 weeks for three cycles. Patients with PR or CR with detectable minimal residual disease (MRD) could receive vemurafenib for up to three additional cycles at the discretion of treating physicians. The side effect profile was similar to the Italian study and included rash, photosensitivity, arthralgia, hand-foot syndrome, and febrile neutropenia. Four patients developed new squamous cell carcinoma (n=3) and cutaneous basal-cell carcinoma (n=1), which were successfully resected. Vemurafenib was reduced to 480 mg twice daily in 14 patients. Blood counts recovered in all patients and 41% of the patients achieved CR. At 1 year after response, the cumulative incidence of relapse was 27% (95% CI, 7 to 51)<sup><a href="#ref-53">53</a></sup>.</p><p class="" id=d21832e1083>The combined results of these two prospective studies provide good evidence that vemurafenib has potent antitumor activity in patients with relapsed and refractory <i>BRAF</i> mutant HCL and confirm the central role of MAP kinase signaling in the pathogenesis of HCL.</p></div><div class=section><a name=d21832e1090 class=n-a></a><h3 class=section-title>Retreatment with vemurafenib</h3><p class="" id=d21832e1095>Despite striking anti-HCL activity of vemurafenib, relapses after drug discontinuation are common, even in patients with CR. Although it cannot be excluded that the selection of highly refractory patients in these studies contributed to the high proportion of early relapses, responses achieved with vemurafenib appear to be less durable than responses achieved with purine analogs.</p><p class="" id=d21832e1098>Relapsing patients can successfully be retreated with vemurafenib<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. Furthermore, Bailleux <i>et al</i>. reported that vemurafenib at a dose of 240 mg once daily was sufficient to maintain a complete hematological remission after an initial induction treatment with low-dose vemurafenib (2  240 mg)<sup><a href="#ref-54">54</a></sup>. Whether continuous or intermittent treatment with vemurafenib is superior remains to be shown, but studies in <i>BRAF</i> mutant melanoma mouse models suggest that intermittent treatment might be advantageous<sup><a href="#ref-55">55</a></sup>. Some genetic lesions have been reported to cause resistance to BRAF inhibition in HCL, including <i>RAS</i><sup><a href="#ref-53">53</a></sup>, <i>PI3K</i><sup><a href="#ref-52">52</a></sup>, and <i>IRS1</i> mutations or loss of <i>NF1</i> and <i>NF2</i><sup><a href="#ref-12">12</a></sup>. However, resistance formation in HCL seems to be a rare event compared to melanoma patients in whom almost all tumors inevitably develop resistance to vemurafenib within months.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21832e1152>Perspective</h2><p class="" id=d21832e1155>There is compelling evidence that BRAF inhibitors are clinically highly efficacious in HCL. However, the high percentage of incomplete responses and the lack of sustained remissions off drug call for the development of combination approaches. BRAF inhibitors could, for instance, be combined with anti-CD20 monoclonal antibodies to potentially eradicate BRAF inhibitor-resistant hairy cell leukemia cells. Patients with metastatic melanoma have been successfully treated with combined BRAF and MEK blockade<sup><a href="#ref-56">56</a></sup>, and the discovery of the reactivation of the MAPK pathway as a probable mode of resistance to vemurafenib in some patients also validates the use of this therapy. Studies for both approaches are on their way.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d21832e1 class=n-a></a><h2 class=main-title id=d22020>Competing interests</h2><p class=metadata-entry><a name=d21832e123 class=n-a></a><p id=d21832e124> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d21832e1 class=n-a></a><h2 class=main-title id=d22022>Grant information</h2><p>Sascha Dietrich was supported by a grant of the Hairy Cell Leukemia Foundation, the Heidelberg Research Centre for Molecular Medicine (HRCMM), and a BMBF Junior Group grant.</p></div><div class=back-section><a name=d21832e1166 class=n-a></a><h2 class=main-title id=d21832e1168>Acknowledgments</h2><p class="" id=d21832e1171>All authors contributed equally to this work.</p></div><div class=back-section><a name=d21832e1175 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d22208>References</h2><div class="section ref-list"><a name=d21832e1175 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d21832e1182 class=n-a></a>BOURONCLE BA, WISEMAN BK, DOAN CA: Leukemic reticuloendotheliosis. <i>Blood.</i> 1958; <b>13</b>(7): 60930. <a target=xrefwindow id=d21832e1190 href="http://www.ncbi.nlm.nih.gov/pubmed/13560561">PubMed Abstract </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726732615"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e1199 class=n-a></a>Teras LR, DeSantis CE, Cerhan JR, <i> et al.</i>: 2016 US lymphoid malignancy statistics by World Health Organization subtypes. <i>CA Cancer J Clin.</i> 2016; <b>66</b>(6): 443459. <a target=xrefwindow id=d21832e1210 href="http://www.ncbi.nlm.nih.gov/pubmed/27618563">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1213 href="http://dx.doi.org/10.3322/caac.21357">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726732615">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d21832e1226 class=n-a></a>Tadmor T, Polliack A: Epidemiology and environmental risk in hairy cell leukemia. <i>Best Pract Res Clin Haematol.</i> 2015; <b>28</b>(4): 1759. <a target=xrefwindow id=d21832e1234 href="http://www.ncbi.nlm.nih.gov/pubmed/26614895">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1237 href="http://dx.doi.org/10.1016/j.beha.2015.10.014">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d21832e1246 class=n-a></a>Schrek R, Donnelly WJ: "Hairy" cells in blood in lymphoreticular neoplastic disease and "flagellated" cells of normal lymph nodes. <i>Blood.</i> 1966; <b>27</b>(2): 199211. <a target=xrefwindow id=d21832e1254 href="http://www.ncbi.nlm.nih.gov/pubmed/5322749">PubMed Abstract </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d21832e1263 class=n-a></a>Grever MR, Abdel-Wahab O, Andritsos LA, <i> et al.</i>: Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. <i>Blood.</i> 2017; <b>129</b>(5): 55360. <a target=xrefwindow id=d21832e1274 href="http://www.ncbi.nlm.nih.gov/pubmed/27903528">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1277 href="http://dx.doi.org/10.1182/blood-2016-01-689422">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1281 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5290982">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d21832e1291 class=n-a></a>Tiacci E, Liso A, Piris M, <i> et al.</i>: Evolving concepts in the pathogenesis of hairy-cell leukaemia. <i>Nat Rev Cancer.</i> 2006; <b>6</b>(6): 43748. <a target=xrefwindow id=d21832e1302 href="http://www.ncbi.nlm.nih.gov/pubmed/16723990">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1305 href="http://dx.doi.org/10.1038/nrc1888">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d21832e1314 class=n-a></a>Basso K, Liso A, Tiacci E, <i> et al.</i>: Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. <i>J Exp Med.</i> 2004; <b>199</b>(1): 5968. <a target=xrefwindow id=d21832e1325 href="http://www.ncbi.nlm.nih.gov/pubmed/14707115">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1328 href="http://dx.doi.org/10.1084/jem.20031175">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1332 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1887727">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725719562"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e1341 class=n-a></a>Robak T, Matutes E, Catovsky D, <i> et al.</i>: Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. <i>Ann Oncol.</i> 2015; <b>26 Suppl 5</b>: v1007. <a target=xrefwindow id=d21832e1352 href="http://www.ncbi.nlm.nih.gov/pubmed/26269205">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1355 href="http://dx.doi.org/10.1093/annonc/mdv200">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725719562">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d21832e1368 class=n-a></a>Tiacci E, Schiavoni G, Forconi F, <i> et al.</i>: Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the <i>BRAF</i>-V600E mutation. <i>Blood.</i> 2012; <b>119</b>(1): 1925. <a target=xrefwindow id=d21832e1382 href="http://www.ncbi.nlm.nih.gov/pubmed/22028477">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1386 href="http://dx.doi.org/10.1182/blood-2011-08-371179">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11443956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e1395 class=n-a></a>Tiacci E, Trifonov V, Schiavoni G, <i> et al.</i>: <i>BRAF</i> mutations in hairy-cell leukemia. <i>N Engl J Med.</i> 2011; <b>364</b>(24): 230515. <a target=xrefwindow id=d21832e1409 href="http://www.ncbi.nlm.nih.gov/pubmed/21663470">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1413 href="http://dx.doi.org/10.1056/NEJMoa1014209">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1416 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3689585">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11443956">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718356371"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e1429 class=n-a></a>Samuel J, Macip S, Dyer MJ: Efficacy of vemurafenib in hairy-cell leukemia. <i>N Engl J Med.</i> 2014; <b>370</b>(3): 2868. <a target=xrefwindow id=d21832e1437 href="http://www.ncbi.nlm.nih.gov/pubmed/24428489">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1440 href="http://dx.doi.org/10.1056/NEJMc1310849">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718356371">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d21832e1454 class=n-a></a>Durham BH, Getta B, Dietrich S, <i> et al.</i>: Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations. <i>Blood.</i> 2017; <b>130</b>(14): 16448. <a target=xrefwindow id=d21832e1465 href="http://www.ncbi.nlm.nih.gov/pubmed/28801450">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1468 href="http://dx.doi.org/10.1182/blood-2017-01-765107">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1472 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5630011">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d21832e1481 class=n-a></a>Tschernitz S, Flossbach L, Bonengel M, <i> et al.</i>: Alternative <i>BRAF</i> mutations in <i>BRAF</i> V600E-negative hairy cell leukaemias. <i>Br J Haematol.</i> 2014; <b>165</b>(4): 52933. <a target=xrefwindow id=d21832e1499 href="http://www.ncbi.nlm.nih.gov/pubmed/24433452">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1502 href="http://dx.doi.org/10.1111/bjh.12735">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d21832e1511 class=n-a></a>Tiacci E, Pettirossi V, Schiavoni G, <i> et al.</i>: Genomics of Hairy Cell Leukemia. <i>J Clin Oncol.</i> 2017; <b>35</b>(9): 100210. <a target=xrefwindow id=d21832e1522 href="http://www.ncbi.nlm.nih.gov/pubmed/28297625">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1525 href="http://dx.doi.org/10.1200/JCO.2016.71.1556">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1529 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5455681">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d21832e1538 class=n-a></a>Falini B, Martelli MP, Tiacci E: <i>BRAF</i> V600E mutation in hairy cell leukemia: from bench to bedside. <i>Blood.</i> 2016; <b>128</b>(15): 191827. <a target=xrefwindow id=d21832e1549 href="http://www.ncbi.nlm.nih.gov/pubmed/27554081">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1552 href="http://dx.doi.org/10.1182/blood-2016-07-418434">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d21832e1561 class=n-a></a>Chung SS, Kim E, Park JH, <i> et al.</i>: Hematopoietic stem cell origin of <i>BRAF</i>V600E mutations in hairy cell leukemia. <i>Sci Transl Med.</i> 2014; <b>6</b>(238): 238ra71. <a target=xrefwindow id=d21832e1575 href="http://www.ncbi.nlm.nih.gov/pubmed/24871132">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1579 href="http://dx.doi.org/10.1126/scitranslmed.3008004">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1582 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4501573">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d21832e1591 class=n-a></a>Ribas A, Flaherty KT: BRAF targeted therapy changes the treatment paradigm in melanoma. <i>Nat Rev Clin Oncol.</i> 2011; <b>8</b>(7): 42633. <a target=xrefwindow id=d21832e1599 href="http://www.ncbi.nlm.nih.gov/pubmed/21606968">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1602 href="http://dx.doi.org/10.1038/nrclinonc.2011.69">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d21832e1612 class=n-a></a>Dietrich S, Hllein J, Hundemer M, <i> et al.</i>: Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia. <i>J Clin Oncol.</i> 2013; <b>31</b>(19): e3003. <a target=xrefwindow id=d21832e1623 href="http://www.ncbi.nlm.nih.gov/pubmed/23690412">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1626 href="http://dx.doi.org/10.1200/JCO.2012.45.9495">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d21832e1635 class=n-a></a>Tiacci E, Schiavoni G, Martelli MP, <i> et al.</i>: Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. <i>Haematologica.</i> 2013; <b>98</b>(4): 6359. <a target=xrefwindow id=d21832e1646 href="http://www.ncbi.nlm.nih.gov/pubmed/23349307">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1649 href="http://dx.doi.org/10.3324/haematol.2012.078071">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1653 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3659996">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d21832e1662 class=n-a></a>Pettirossi V, Santi A, Imperi E, <i> et al.</i>: BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity. <i>Blood.</i> 2015; <b>125</b>(8): 120716. <a target=xrefwindow id=d21832e1673 href="http://www.ncbi.nlm.nih.gov/pubmed/25480661">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1676 href="http://dx.doi.org/10.1182/blood-2014-10-603100">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1680 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4366655">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d21832e1689 class=n-a></a>Robak T: Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment. <i>Cancer Treat Rev.</i> 2011; <b>37</b>(1): 310. <a target=xrefwindow id=d21832e1697 href="http://www.ncbi.nlm.nih.gov/pubmed/20558005">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1700 href="http://dx.doi.org/10.1016/j.ctrv.2010.05.003">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d21832e1709 class=n-a></a>Xi L, Arons E, Navarro W, <i> et al.</i>: Both variant and IGHV4-34-expressing hairy cell leukemia lack the <i>BRAF</i> V600E mutation. <i>Blood.</i> 2012; <b>119</b>(14): 33302. <a target=xrefwindow id=d21832e1723 href="http://www.ncbi.nlm.nih.gov/pubmed/22210875">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1727 href="http://dx.doi.org/10.1182/blood-2011-09-379339">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1730 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3321859">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718406497"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e1739 class=n-a></a>Waterfall JJ, Arons E, Walker RL, <i> et al.</i>: High prevalence of <i>MAP2K1</i> mutations in variant and IGHV4-34-expressing hairy-cell leukemias. <i>Nat Genet.</i> 2014; <b>46</b>(1): 810. <a target=xrefwindow id=d21832e1753 href="http://www.ncbi.nlm.nih.gov/pubmed/24241536">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1757 href="http://dx.doi.org/10.1038/ng.2828">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1760 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3905739">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718406497">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d21832e1774 class=n-a></a>Venkataraman G, Aguhar C, Kreitman RJ, <i> et al.</i>: Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders. <i>Am J Clin Pathol.</i> 2011; <b>136</b>(4): 62530. <a target=xrefwindow id=d21832e1785 href="http://www.ncbi.nlm.nih.gov/pubmed/21917686">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1788 href="http://dx.doi.org/10.1309/AJCPKUM9J4IXCWEU">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d21832e1797 class=n-a></a>Sandes AF, de Lourdes Chauffaille M, Oliveira CR, <i> et al.</i>: CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry. <i>Cytometry B Clin Cytom.</i> 2014; <b>86</b>(2): 98105. <a target=xrefwindow id=d21832e1808 href="http://www.ncbi.nlm.nih.gov/pubmed/24243815">PubMed Abstract </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d21832e1817 class=n-a></a>Pillai V, Pozdnyakova O, Charest K, <i> et al.</i>: CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders. <i>Am J Clin Pathol.</i> 2013; <b>140</b>(4): 53643. <a target=xrefwindow id=d21832e1828 href="http://www.ncbi.nlm.nih.gov/pubmed/24045551">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1831 href="http://dx.doi.org/10.1309/AJCPEBK31VQQNDDR">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726221128"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e1840 class=n-a></a>Swerdlow SH, Campo E, Pileri SA, <i> et al.</i>: The 2016 revision of the World Health Organization classification of lymphoid neoplasms. <i>Blood.</i> 2016; <b>127</b>(20): 237590. <a target=xrefwindow id=d21832e1851 href="http://www.ncbi.nlm.nih.gov/pubmed/26980727">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1854 href="http://dx.doi.org/10.1182/blood-2016-01-643569">Publisher Full Text </a> | <a target=xrefwindow id=d21832e1858 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4874220">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726221128">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d21832e1871 class=n-a></a>Falini B, Tiacci E, Liso A, <i> et al.</i>: Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). <i>Lancet.</i> 2004; <b>363</b>(9424): 186970. <a target=xrefwindow id=d21832e1882 href="http://www.ncbi.nlm.nih.gov/pubmed/15183626">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1885 href="http://dx.doi.org/10.1016/S0140-6736(04)16356-3">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d21832e1894 class=n-a></a>Andrulis M, Penzel R, Weichert W, <i> et al.</i>: Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia. <i>Am J Surg Pathol.</i> 2012; <b>36</b>(12): 1796800. <a target=xrefwindow id=d21832e1905 href="http://www.ncbi.nlm.nih.gov/pubmed/22531170">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1908 href="http://dx.doi.org/10.1097/PAS.0b013e3182549b50">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725292083"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e1918 class=n-a></a>Uppal G, Ly V, Wang ZX, <i> et al.</i>: The utility of <i>BRAF</i> V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia. <i>Am J Clin Pathol.</i> 2015; <b>143</b>(1): 1205. <a target=xrefwindow id=d21832e1932 href="http://www.ncbi.nlm.nih.gov/pubmed/25511150">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1936 href="http://dx.doi.org/10.1309/AJCPQLQ89VXTVWKN">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725292083">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d21832e1949 class=n-a></a>Dietrich S, Hllein J, Lee SC, <i> et al.</i>: Recurrent <i>CDKN1B</i> (p27) mutations in hairy cell leukemia. <i>Blood.</i> 2015; <b>126</b>(8): 10058. <a target=xrefwindow id=d21832e1963 href="http://www.ncbi.nlm.nih.gov/pubmed/26065650">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1967 href="http://dx.doi.org/10.1182/blood-2015-04-643361">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d21832e1976 class=n-a></a>Chu IM, Hengst L, Slingerland JM: The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. <i>Nat Rev Cancer.</i> 2008; <b>8</b>(4): 25367. <a target=xrefwindow id=d21832e1984 href="http://www.ncbi.nlm.nih.gov/pubmed/18354415">PubMed Abstract </a> | <a target=xrefwindow id=d21832e1987 href="http://dx.doi.org/10.1038/nrc2347">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1027327"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e1996 class=n-a></a>Michaloglou C, Vredeveld LC, Soengas MS, <i> et al.</i>: BRAF<sup>E600</sup>-associated senescence-like cell cycle arrest of human naevi. <i>Nature.</i> 2005; <b>436</b>(7051): 7204. <a target=xrefwindow id=d21832e2010 href="http://www.ncbi.nlm.nih.gov/pubmed/16079850">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2014 href="http://dx.doi.org/10.1038/nature03890">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1027327">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732879576"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2027 class=n-a></a>Piva R, Deaglio S, Fam R, <i> et al.</i>: The Krppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. <i>Leukemia.</i> 2015; <b>29</b>(2): 5037. <a target=xrefwindow id=d21832e2038 href="http://www.ncbi.nlm.nih.gov/pubmed/25283840">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2041 href="http://dx.doi.org/10.1038/leu.2014.294">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732879576">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725249263"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2054 class=n-a></a>Clipson A, Wang M, de Leval L, <i> et al.</i>: <i>KLF2</i> mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. <i>Leukemia.</i> 2015; <b>29</b>(5): 117785. <a target=xrefwindow id=d21832e2068 href="http://www.ncbi.nlm.nih.gov/pubmed/25428260">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2072 href="http://dx.doi.org/10.1038/leu.2014.330">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725249263">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d21832e2086 class=n-a></a>Grever M, Kopecky K, Foucar MK, <i> et al.</i>: Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. <i>J Clin Oncol.</i> 1995; <b>13</b>(4): 97482. <a target=xrefwindow id=d21832e2097 href="http://www.ncbi.nlm.nih.gov/pubmed/7707126">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2100 href="http://dx.doi.org/10.1200/JCO.1995.13.4.974">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d21832e2109 class=n-a></a>Catovsky D, Matutes E, Talavera JG, <i> et al.</i>: Long term results with 2'deoxycoformycin in hairy cell leukemia. <i>Leuk Lymphoma.</i> 1994; <b>14 Suppl 1</b>: 10913. <a target=xrefwindow id=d21832e2120 href="http://www.ncbi.nlm.nih.gov/pubmed/7820041">PubMed Abstract </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d21832e2129 class=n-a></a>Hoffman MA, Janson D, Rose E, <i> et al.</i>: Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. <i>J Clin Oncol.</i> 1997; <b>15</b>(3): 113842. <a target=xrefwindow id=d21832e2140 href="http://www.ncbi.nlm.nih.gov/pubmed/9060556">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2143 href="http://dx.doi.org/10.1200/JCO.1997.15.3.1138">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d21832e2152 class=n-a></a>Piro LD, Carrera CJ, Carson DA, <i> et al.</i>: Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. <i>N Engl J Med.</i> 1990; <b>322</b>(16): 111721. <a target=xrefwindow id=d21832e2163 href="http://www.ncbi.nlm.nih.gov/pubmed/1969613">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2166 href="http://dx.doi.org/10.1056/NEJM199004193221605">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725969421"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2175 class=n-a></a>Else M, Dearden CE, Catovsky D: Long-term follow-up after purine analogue therapy in hairy cell leukaemia. <i>Best Pract Res Clin Haematol.</i> 2015; <b>28</b>(4): 21729. <a target=xrefwindow id=d21832e2183 href="http://www.ncbi.nlm.nih.gov/pubmed/26614900">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2186 href="http://dx.doi.org/10.1016/j.beha.2015.09.004">Publisher Full Text </a> | <a target=xrefwindow id=d21832e2189 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5509559">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725969421">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d21832e2201 class=n-a></a>Else M, Dearden CE, Matutes E, <i> et al.</i>: Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. <i>Br J Haematol.</i> 2009; <b>145</b>(6): 73340. <a target=xrefwindow id=d21832e2212 href="http://www.ncbi.nlm.nih.gov/pubmed/19344416">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2215 href="http://dx.doi.org/10.1111/j.1365-2141.2009.07668.x">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718358963"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2225 class=n-a></a>Cornet E, Tomowiak C, Tanguy-Schmidt A, <i> et al.</i>: Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia. <i>Br J Haematol.</i> 2014; <b>166</b>(3): 390400. <a target=xrefwindow id=d21832e2236 href="http://www.ncbi.nlm.nih.gov/pubmed/24749839">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2239 href="http://dx.doi.org/10.1111/bjh.12908">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718358963">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d21832e2252 class=n-a></a>Kraut EH, Grever MR, Bouroncle BA: Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycin. <i>Blood.</i> 1994; <b>84</b>(12): 40613. <a target=xrefwindow id=d21832e2260 href="http://www.ncbi.nlm.nih.gov/pubmed/7994024">PubMed Abstract </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d21832e2269 class=n-a></a>Saven A, Burian C, Koziol JA, <i> et al.</i>: Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. <i>Blood.</i> 1998; <b>92</b>(6): 191826. <a target=xrefwindow id=d21832e2280 href="http://www.ncbi.nlm.nih.gov/pubmed/9731048">PubMed Abstract </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5725958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2289 class=n-a></a>Flaherty KT, Puzanov I, Kim KB, <i> et al.</i>: Inhibition of mutated, activated BRAF in metastatic melanoma. <i>N Engl J Med.</i> 2010; <b>363</b>(9): 80919. <a target=xrefwindow id=d21832e2300 href="http://www.ncbi.nlm.nih.gov/pubmed/20818844">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2303 href="http://dx.doi.org/10.1056/NEJMoa1002011">Publisher Full Text </a> | <a target=xrefwindow id=d21832e2307 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3724529">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5725958">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d21832e2320 class=n-a></a>Dietrich S, Glimm H, Andrulis M, <i> et al.</i>: BRAF inhibition in refractory hairy-cell leukemia. <i>N Engl J Med.</i> 2012; <b>366</b>(21): 203840. <a target=xrefwindow id=d21832e2331 href="http://www.ncbi.nlm.nih.gov/pubmed/22621641">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2334 href="http://dx.doi.org/10.1056/NEJMc1202124">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733061215"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2343 class=n-a></a>Follows GA, Sims H, Bloxham DM, <i> et al.</i>: Rapid response of biallelic <i>BRAF</i> V600E mutated hairy cell leukaemia to low dose vemurafenib. <i>Br J Haematol.</i> 2013; <b>161</b>(1): 1503. <a target=xrefwindow id=d21832e2357 href="http://www.ncbi.nlm.nih.gov/pubmed/23278307">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2361 href="http://dx.doi.org/10.1111/bjh.12201">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733061215">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732809643"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2375 class=n-a></a>Munoz J, Schlette E, Kurzrock R: Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a <i>BRAF</i> mutation. <i>J Clin Oncol.</i> 2013; <b>31</b>(20): e3512. <a target=xrefwindow id=d21832e2386 href="http://www.ncbi.nlm.nih.gov/pubmed/23733763">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2389 href="http://dx.doi.org/10.1200/JCO.2012.45.7739">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732809643">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728069342"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2402 class=n-a></a>Peyrade F, Re D, Ginet C, <i> et al.</i>: Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a <i>V600E</i> mutation. <i>Haematologica.</i> 2013; <b>98</b>(2): e202. <a target=xrefwindow id=d21832e2416 href="http://www.ncbi.nlm.nih.gov/pubmed/23300174">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2420 href="http://dx.doi.org/10.3324/haematol.2012.082404">Publisher Full Text </a> | <a target=xrefwindow id=d21832e2423 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3561446">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728069342">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718426341"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2436 class=n-a></a>Vergote V, Dierickx D, Janssens A, <i> et al.</i>: Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib. <i>Ann Hematol.</i> 2014; <b>93</b>(12): 20879. <a target=xrefwindow id=d21832e2447 href="http://www.ncbi.nlm.nih.gov/pubmed/24863690">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2450 href="http://dx.doi.org/10.1007/s00277-014-2104-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718426341">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733061218"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2463 class=n-a></a>Maurer H, Haas P, Wengenmayer T, <i> et al.</i>: Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis. <i>Ann Hematol.</i> 2014; <b>93</b>(8): 143940. <a target=xrefwindow id=d21832e2474 href="http://www.ncbi.nlm.nih.gov/pubmed/24337488">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2477 href="http://dx.doi.org/10.1007/s00277-013-1987-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733061218">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d21832e2490 class=n-a></a>Dietrich S, Pircher A, Endris V, <i> et al.</i>: BRAF inhibition in hairy cell leukemia with low-dose vemurafenib. <i>Blood.</i> 2016; <b>127</b>(23): 284755. <a target=xrefwindow id=d21832e2501 href="http://www.ncbi.nlm.nih.gov/pubmed/26941398">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2504 href="http://dx.doi.org/10.1182/blood-2015-11-680074">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d21832e2513 class=n-a></a>Tiacci E, Park JH, de Carolis L, <i> et al.</i>: Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia. <i>N Engl J Med.</i> 2015; <b>373</b>(18): 173347. <a target=xrefwindow id=d21832e2524 href="http://www.ncbi.nlm.nih.gov/pubmed/26352686">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2527 href="http://dx.doi.org/10.1056/NEJMoa1506583">Publisher Full Text </a> | <a target=xrefwindow id=d21832e2531 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4811324">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725417281"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2541 class=n-a></a>Bailleux C, Robert G, Ginet C, <i> et al.</i>: Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib. <i>Oncoscience.</i> 2015; <b>2</b>(1): 449. <a target=xrefwindow id=d21832e2552 href="http://www.ncbi.nlm.nih.gov/pubmed/25815361">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2555 href="http://dx.doi.org/10.18632/oncoscience.111">Publisher Full Text </a> | <a target=xrefwindow id=d21832e2559 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4341463">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725417281">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717992185"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2572 class=n-a></a>Das Thakur M, Salangsang F, Landman AS, <i> et al.</i>: Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. <i>Nature.</i> 2013; <b>494</b>(7436): 2515. <a target=xrefwindow id=d21832e2583 href="http://www.ncbi.nlm.nih.gov/pubmed/23302800">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2586 href="http://dx.doi.org/10.1038/nature11814">Publisher Full Text </a> | <a target=xrefwindow id=d21832e2590 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3930354">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717992185">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726068976"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21832e2603 class=n-a></a>Eroglu Z, Ribas A: Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy. <i>Ther Adv Med Oncol.</i> 2016; <b>8</b>(1): 4856. <a target=xrefwindow id=d21832e2611 href="http://www.ncbi.nlm.nih.gov/pubmed/26753005">PubMed Abstract </a> | <a target=xrefwindow id=d21832e2614 href="http://dx.doi.org/10.1177/1758834015616934">Publisher Full Text </a> | <a target=xrefwindow id=d21832e2617 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4699264">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726068976">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Apr 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-509/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-509/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medicine V, University of Heidelberg, Heidelberg, Germany<br/> <sup>2</sup> Institute of Hematology and Center for Hemato-Oncology Research (CREO), University and Hospital of Perugia, Perugia, Italy<br/> <p> <div class=margin-bottom> Tobias Roider <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Brunangelo Falini <br/> <span>Roles: </span> Conceptualization, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Sascha Dietrich <br/> <span>Roles: </span> Conceptualization, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-509/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 27 Apr 2018, 7:509 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.13265.1">https://doi.org/10.12688/f1000research.13265.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2018 Roider T <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=14391 data-id=13265 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13265.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-509/v1/pdf?article_uuid=7a150471-ec1c-4a00-8e4f-87e1ce1dfe52" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.13265.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Roider T, Falini B and Dietrich S. Recent advances in understanding and managing hairy cell leukemia [version 1; peer review: 4 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):509 (<a href="https://doi.org/10.12688/f1000research.13265.1" target=_blank>https://doi.org/10.12688/f1000research.13265.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=13265 id=mobile-track-article-signin-13265 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13265?target=/articles/7-509/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=14391 /> <input name=articleId type=hidden value=13265 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Tadeusz Robak</strong>, Department of Hematology, Medical University of Lodz, Poland </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Guldeep Uppal</strong>, Division of Hematopathology, Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Daniel Catovsky</strong>, Division of Molecular Pathology, The Institute of Cancer Research, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Peter Wiernik</strong>, Cancer Research Foundation, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Apr 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-509/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-509/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=33747-33304></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=33748-33307></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=33750-33306></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=33749-33305></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-509/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>27 Apr 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Tadeusz Robak</strong>, Department of Hematology, Medical University of Lodz, Poland </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Guldeep Uppal</strong>, Division of Hematopathology, Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Daniel Catovsky</strong>, Division of Molecular Pathology, The Institute of Cancer Research, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Peter Wiernik</strong>, Cancer Research Foundation, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-509/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-509/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding and managing...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-509/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-509/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-509/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Roider T et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-509/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-509",
            templates : {
                twitter : "Recent advances in understanding and managing hairy cell leukemia. Roider T et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-509/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding and managing hairy cell leukemia", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding and managing hairy cell leukemia", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/13265/14391")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "14391");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "33304": 0,
                           "33305": 0,
                           "33306": 0,
                           "33307": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "772261ad-8754-4246-9dee-d37b2d6554fa";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-509.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-509.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-509.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-509.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-509.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>